The level of CD26 determines the rate of HIV entry in a CD4+ T-cell line

Advances in Experimental Medicine and Biology

Volumn 421, Issue , 1997, Pages 179-184

  Callebaut, Christian ^a   Jacotot, Etienne ^a   Blanco, Julià ^a   Krust, Bernard ^a   Hovanessian, Ara G ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; MEMBRANE ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE CLONE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030862689     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-9613-1_23     Document Type: Article

References (33)

1. Fleischer, B, CD26: a surface protease involved in T-cell activation. Immunol Today, 1994. 15(4): p. 180-4.
2. Callebaut, C, et al., T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells. Science, 1993. 262(5142): p. 2045-50.
3. Callebaut, C, et al., Entry of HIV into CD4+ cells requires the T-cell activation antigen CD26/DPP IV, in Villè Colloque des Cent Gardes, M. Girard and B. Dodet, Editors. 1993b, In Retrovirus of Human AIDS and related diseases: p. 187-193.
4. Broder, CC, et al., CD26 antigen and HIV fusion? [letter; comment]. Science, 1994. 264(5162): p. 1156-9.
5. Patience, C, et al., CD26 antigen and HIV fusion? [letter; comment]. Science, 1994. 264(5162): p. 1159-60.
6. Camerini, D, Planelles, V, and Chen, IS, CD26 antigen and HIV fusion? [letter; comment]. Science, 1994. 264(5162): p. 1160-1.
7. Alizon, M and Dragic, T, CD26 antigen and HIV fusion? [letter; comment]. Science, 1994. 264(5162): p. 1161-2.
8. Callebaut, C, et al., CD26 antigen and HIV fusion? [Response]. Science, 1994. 264(20 May 1994): p. 1156-1165.
9. Oravecz, T, et al., CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV-1 strains in a T-cell line [see comments]. Nat Med, 1995. 1(9): p. 919-26.
10. Callebaut, C and Hovanessian, AG, CD26 and HIV infection. Res. Virol., 1996. 147: p. 67-69.
11. Chin, LT, et al., Molecular characterization of a human anti-HIV 1 monoclonal antibody revealed a CD26-related motif in CDR2. Immunology Letters, 1995. 44: p. 25-30.
12. Callebaut, C, et al., The role of CD26 in HIV infection viral entry and its cytopathic effect, in IXe Colloque des Cent Gardes, M. Girard and B. Dodet, Editors. 1994b, In Retrovirus of Human AIDS and related diseases: p. 141-149.
13. + T cells. Virology, 1996. 223: p. 318-330.
14. Moore, JP, et al., The HIV-cell fusion reaction, in Viral Fusion Mechanisms, J. Bentz, Editor. 1993, p. 233-289.
15. Laurent-Crawford, AG, et al., Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. Aids Res Hum Retroviruses, 1993. 9(8): p. 761-73.
16. Maddon, PJ, et al., The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell, 1986. 47: p. 333-348.
17. Sattentau, QJ and Moore, JP, Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J Exp Med, 1991. 174(2): p. 407-15.
18. Schulz, TF, et al., Effect of mutations in the V3 loop of HIV-1 gp120 on infectivity and susceptibility to proteolytic cleavage. Aids Res Hum Retroviruses, 1993. 9(2): p. 159-66.
19. Dragic, T, Picard, L, and Alizon, M, Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins. J Virol, 1995. 69(2): p. 1013-8.
20. Feng, Y, et al., HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane. G protein-coupled receptor [see comments]. Science, 1996. 272(5263): p. 872-7.
21. Dragic, T, et al., HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature, 1996. 381: p. 667-673.
22. + T cells, in Cellular Peptidases in Immune Functions and Diseases. S. Ansorge and J. Langner, Editors. Plenum: 1997, p. 207-216.
23. Valenzuela, A, et al., HIV-1 envelope gp120 and viral particles block adenosine deaminase binding to human CD26, in Cellular Peptidases in Immune Functions and Diseases, S. Ansorge and J. Langner, Editors. Plenum: 1997, p. 185-192.
24. Pantaleo, G, et al., Dissociation between syncytia formation and HIV spreading. Suppression of syncytia formation does not necessarily reflect inhibition of HIV infection. Eur. J. Immunol., 1991. 21: p. 1771-1774.
25. Tanaka, T, et al., Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proc Natl Acad Sci USA, 1994. 91(8): p. 3082-6.
26. Kameoka, J, et al., Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science, 1993. 261(5120): p. 466-9.
27. Martin, M, et al., Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule. J Immunol, 1995. 155(10): p. 4630-43
28. Dong, RP, et al., Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J Immunol, 1996. 156(4): p. 1349-55.
29. Hershfield, MS and Mitchell, BS, Immunodeficiency diseases caused by adenosine deaminase deficiency and purinenucleoside phosphorylase deficiency, in The Metabolic and Molecular Bases of Inherited Disease, S. C. R., et al., Editors. 1995, p. 1745-1768.
30. Mentlein, R, et al., Influence of pregnancy on dipeptidyl peptidase IV activity (CD 26 leukocyte differentiation antigen) of circulating lymphocytes. Eur J Clin Chem Clin Biochem, 1991. 29(8): p. 477-80.
31. Rich, KC, et al., CD4+ lymphocytes in perinatal human immunodeficiency virus (HIV) infection: evidence for pregnancy-induced immune depression in uninfected and HIV-infected women. J Infect Dis, 1995. 172(5): p. 1221-7.
32. Graziosi, C, et al., HIV-1 infection in the lymphoid organs. Aids, 1993. 7(2): p. S53-8.
33. Gougeon, M-L, et al., Selective loss of CD4+/CD26+ T cell subset during HIV infection. Res. Immunol, 1996. 147, 5-8.